FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19195411000001104: Naproxen 250mg tablets (Aurobindo Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65074801000001117 Naproxen 250mg tablets (Aurobindo Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106645501000001113 Naproxen 250mg tablets (Milpharm Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Is a Naproxen 250mg tablets true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Is a Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has active ingredient Naproxen false Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has specific active ingredient Naproxen true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Aurobindo Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Naproxen 250mg tablets (Aurobindo Pharma Ltd) 28 tablet Has AMP True Naproxen 250mg tablets (Aurobindo Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start